Healthpeak Properties, Inc. (NYSE:DOC) Receives $23.92 Average Target Price from Brokerages

Shares of Healthpeak Properties, Inc. (NYSE:DOC) have earned a consensus recommendation of “Moderate Buy” from the fourteen brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $23.92.

A number of research firms have recently issued reports on DOC. Scotiabank cut their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. Wedbush cut their price objective on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a report on Friday, February 14th. Robert W. Baird dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Tuesday, February 11th. Wells Fargo & Company dropped their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a report on Tuesday, December 10th. Finally, Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of DOC. Mizuho Bank Ltd. bought a new position in Healthpeak Properties during the 4th quarter valued at approximately $28,000. Harvest Fund Management Co. Ltd bought a new position in shares of Healthpeak Properties in the 4th quarter worth approximately $30,000. Avior Wealth Management LLC bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $37,000. Groupama Asset Managment bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $37,000. Finally, Covestor Ltd raised its position in shares of Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock worth $37,000 after acquiring an additional 1,152 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Price Performance

DOC opened at $20.52 on Tuesday. The stock has a 50-day moving average price of $20.20 and a 200-day moving average price of $21.30. Healthpeak Properties has a 12-month low of $16.66 and a 12-month high of $23.26. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $14.35 billion, a P/E ratio of 58.62, a PEG ratio of 2.17 and a beta of 1.14.

Healthpeak Properties Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a dividend of $0.305 per share. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date was Friday, February 14th. This represents a $1.22 dividend on an annualized basis and a yield of 5.95%. Healthpeak Properties’s dividend payout ratio is presently 348.57%.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.